Acta Scientific Veterinary Sciences (ISSN: 2582-3183)

Review Article Volume 4 Issue 3

Obstacles in Phytopharmaceutical Drug Discovery and the Urgent Need for Regulatory and Funding System Reformation

Shankar Ganesh Kanabathy

Department of NIL, Natures Remedies, Malaysia

*Corresponding Author: Shankar Ganesh Kanabathy, Department of NIL, Natures Remedies, Malaysia.

Received: January 19, 2022; Published: February 17, 2022

Abstract

The global healthcare industry particularly the pharmaceutical industry faces challenges such as toxicity, food residues and microbial resistance. Therefore, the industry has to be transformed towards phytopharmaceuticals to alleviate adverse effects. However, the natural product drug discovery faces stringent regulatory issues, pharmaceutical monopoly and funding constraints. Therefore, the formulation of favorable laws and regulations, is vital, to spur the industry to enable the discoveries of phytopharmaceutical; that may initiate the bioeconomy of tropical countries; especially the poor ones in Asia.

Keywords: Natural Product Drug Discovery; Favorable Regulation; Funding

References

  1.  
  2. Antara Sen and Amla Batra. “Chemical composition of methanol extract of the leaves of Melia azedarach L”. Asian Journal of Pharmaceutical and Clinical Research3 (2012).
  3. Anuj Arora. “Natural and safe alternates for expensive synthetic nutrition”. Proceedings in the 3rd International Conference on Animal Nutrition (ICAN) (2008): 73-78.
  4. Chris Chan. “It is in the process”. Fit for Life. Star Publication (2015): 11.
  5. Chris Chan. “The new abnormal”. Star Publication (2020).
  6. Chris Chan. “Living with the next pandemic”. Star Publication (2020).
  7. Daniel S Fabricant and Norman R Fansworth. “The value of plants used in traditional medicine for drug discovery”. Program for collaborative research in the pharmaceutical sciences, College of Pharmacy, University of Illinois-Chicago, Illinois, USA (2000).
  8. “Toxics in seafood”. Star Publications (2016): 6.
  9. Gunes H., et al. “Antibacterial effects of curcumin: an in vitro minimum inhibitory concentration study”. Toxicology and Industrial Health 2 (2013): 246-250.
  10. Grethel Aguilar. “On the brink of extinction”. Study: 28,000 species now officially threatened, thank to humans. Star Publication (2019).
  11. Leland J Cseke., et al. “Traditional, analytical and preparative separation of natural products”. Natural Products from Plants. 2nd Taylor and Francis (2006): 263-317.
  12. Leland J Cseke and Peter B Kaufman. “Regulation of metabolic synthesis in plants”. Natural Products from Plants. 2nd Taylor and Francis (2006): 101-141.
  13. Lori Garett Hatfield. “Animals that share human DNA sequences”. Osmopharm SA (2013).
  14. Martin Khor. “Super drug-resistant gene raises new health alarm”. Star Publication (2016): 17.
  15. Peter B Kaufman., et al. “The uses of plant natural products by humans and risk associated with their use”. Natural Products from Plants. 2nd Taylor and Francis (2006): 441-473.
  16. Shahedur Rahman., et al. “Ocimum sanctum L.: A review of phytochemical and pharmacological profile”. American Journal of Drug Discovery and Development (2011).
  17. Shankar Ganesh K. “The use of natural product to treat and prevent disease conditions in livestock. Malaysia Omni Agricultural Directory 2011/2012”. Ministry of Agriculture and Agro Based Industry, Malaysia (2011).
  18. Tan Shiow Chin. “The problem with drug discovery”. Exclusive interview material from Prof Chas Bountra, a professor of translational medicine from the department of clinical medicine, University of Oxford, Nuffield. Star Publications. Fit for Life (2018): 3-4.
  19. TB Alliance. “Progress in TB treatment”. Fit For Life. Star Publications (2016): 11.

Citation

Citation: Shankar Ganesh Kanabathy. “Obstacles in Phytopharmaceutical Drug Discovery and the Urgent Need for Regulatory and Funding System Reformation”. Acta Scientific Veterinary Sciences 4.3 (2022): 40-44.

Copyright

Copyright: © 2022 Shankar Ganesh Kanabathy. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.008

Indexed In





News and Events


Contact US